Corrigendum to 'Extreme temperature increases the risk of COPD morbimortality: A systematic review and meta-analysis [Science of The Total Environment, Vol 958 [2025] 178087'.

Introduction: This systematic review examines how extreme temperatures impact Chronic Obstructive Pulmonary Disease (COPD) morbidity and mortality, focusing on identifying vulnerable subpopulations.

Methods: We conducted a systematic literature search from January 1, 2000, to November 6, 2024, across databases like PubMed, MEDLINE and EMBASE, Web of Science, and Scopus, focusing on observational studies that quantitatively defined extreme temperatures and their impacts on COPD morbidity and mortality. Out of 3140 records, 25 studies met the inclusion criteria.

Telephone Counseling and Messaging Guided by Mobile Profiling of Tobacco Users for Smoking Cessation: A Randomized Clinical Trial.

Importance: Evidence-based pharmacotherapy and behavioral therapy could increase tobacco abstinence but are underused and require further investigation.

Objective: To evaluate the effectiveness of a novel mobile health (mHealth) profiling via ecological momentary assessment (EMA) in personalizing smoking cessation intervention for individuals who use tobacco with no intention to use smoking cessation services and medications.

Design, Setting, And Participants: A 2-arm, assessor-blind, individual-randomized clinical trial was conducted.

Clinically Significant Functional Impairments and Symptoms in COVID-19 Survivors: Empirical Research Quantitative.

Background: COVID-19 survivors may experience complex, distressing and persistent symptoms, referred to as long COVID, lasting months or years after diagnosis. More evidence is needed for effective long COVID screening and management.

Aim: To explore the clinical profile of long COVID and factors associated with its development.

Undiagnosed Lymphoma Detected During Routine Histocompatibility Crossmatch: Three Case Reports.

Unexpected transmission of donor-derived diseases, including infections and malignancies, through organ transplantation are occasionally observed and reported. Subclinical, or otherwise undiagnosed, hematological malignancies in potential donors are rare events and typically not identifiable via standard donor evaluation or laboratory testing. Flow cytometric crossmatching (FCXM) is a specialized assay routinely performed in clinical histocompatibility laboratories for the evaluation of immunological compatibility between the recipients and the organ donors through the detection of donor-specific antibodies.